Genetic variants in CETP increase risk of intracerebral hemorrhage
- PMID: 27717122
- PMCID: PMC5115931
- DOI: 10.1002/ana.24780
Genetic variants in CETP increase risk of intracerebral hemorrhage
Abstract
Objective: In observational epidemiologic studies, higher plasma high-density lipoprotein cholesterol (HDL-C) has been associated with increased risk of intracerebral hemorrhage (ICH). DNA sequence variants that decrease cholesteryl ester transfer protein (CETP) gene activity increase plasma HDL-C; as such, medicines that inhibit CETP and raise HDL-C are in clinical development. Here, we test the hypothesis that CETP DNA sequence variants associated with higher HDL-C also increase risk for ICH.
Methods: We performed 2 candidate-gene analyses of CETP. First, we tested individual CETP variants in a discovery cohort of 1,149 ICH cases and 1,238 controls from 3 studies, followed by replication in 1,625 cases and 1,845 controls from 5 studies. Second, we constructed a genetic risk score comprised of 7 independent variants at the CETP locus and tested this score for association with HDL-C as well as ICH risk.
Results: Twelve variants within CETP demonstrated nominal association with ICH, with the strongest association at the rs173539 locus (odds ratio [OR] = 1.25, standard error [SE] = 0.06, p = 6.0 × 10-4 ) with no heterogeneity across studies (I2 = 0%). This association was replicated in patients of European ancestry (p = 0.03). A genetic score of CETP variants found to increase HDL-C by ∼2.85mg/dl in the Global Lipids Genetics Consortium was strongly associated with ICH risk (OR = 1.86, SE = 0.13, p = 1.39 × 10-6 ).
Interpretation: Genetic variants in CETP associated with increased HDL-C raise the risk of ICH. Given ongoing therapeutic development in CETP inhibition and other HDL-raising strategies, further exploration of potential adverse cerebrovascular outcomes may be warranted. Ann Neurol 2016;80:730-740.
© 2016 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association.
Figures
References
-
- Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet 2014;384:618–625. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K23 NS083711/NS/NINDS NIH HHS/United States
- MR/K026992/1/MRC_/Medical Research Council/United Kingdom
- R01 HG008983/HG/NHGRI NIH HHS/United States
- P50 NS051343/NS/NINDS NIH HHS/United States
- U01 NS069763/NS/NINDS NIH HHS/United States
- R01 NS059727/NS/NINDS NIH HHS/United States
- G1002605/MRC_/Medical Research Council/United Kingdom
- U01 NS036695/NS/NINDS NIH HHS/United States
- R01 AG026484/AG/NIA NIH HHS/United States
- K23 NS086873/NS/NINDS NIH HHS/United States
- G0900428/MRC_/Medical Research Council/United Kingdom
- R01 NS030678/NS/NINDS NIH HHS/United States
- MR/M013111/1/MRC_/Medical Research Council/United Kingdom
- R01 HL127564/HL/NHLBI NIH HHS/United States
- R01 NS036695/NS/NINDS NIH HHS/United States
- L30 NS084073/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
